产品封面图

HCC1954 BL

收藏
  • 询价
  • 2025年09月23日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 物种来源

    • 是否是肿瘤细胞

      0

    • 器官来源

      外周血

    • ATCC Number

      CRL-2339™

    • 细胞类型

      B淋巴细胞

    • 年限

      61 years adult

    • 生长状态

      悬浮生长,多细胞聚集

    • 细胞形态

      淋巴样

    • 库存

      大量

    • 运输方式

      冻存运输

    Designations: HCC1954 BL
    Depositors:  AF Gazdar, AK Virmani
    Biosafety Level: 2 [Cells contain Herpesvirus; Epstein Barr Virus (EBV) ]
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: suspension, multicell aggregates
    Organism: Homo sapiens
    Morphology: lymphoblast

    Source: Organ: peripheral blood
    Cell Type: B lymphoblast; Epstein-Barr virus (EBV) transformed
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Restrictions: The line is available with the following restrictions:
    1. This cell line was deposited at the ATCC by Dr. Adi F. Gazdar and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied.
    2. Any proposed commercial use of the these cells, or their products must first be negotiated with the University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235. Telephone (214) 648-1888, Email TechnologyDevelopment@UTSouthwestern.edu, or Fax: (214) 951-0935.
    Applications: The cell line was derived from a 61 year-old East Indian female with stage IIA, grade 3, primary ductal carcinoma of the breast.
    DNA Profile (STR): Amelogenin: X
    CSF1PO: 10,11
    D13S317: 8,9
    D16S539: 9,11
    D5S818: 11,12
    D7S820: 10,11
    THO1: 6,7
    TPOX: 8,9
    vWA: 18,19
    Age: 61 years adult
    Gender: female
    Ethnicity: East Indian
    Comments: HCC1954 BL is a B lymphoblastoid cell line initiated from peripheral blood lymphocytes from the same patient as HCC1954 (ductal carcinoma of the breast) by transformation with Epstein-Barr virus (EBV).
    The cell line was derived from a 61 year-old East Indian female with stage IIA, grade 3, primary ductal carcinoma of the breast.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Temperature: 37.0°C
    Subculturing: Protocol: Cultures can be maintained by addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension in fresh medium at 3 to 5 x 10 exp5 viable cells/ml. Maintain cultures at cell concentrations between 5 X 10 exp5 and 2 X 10 exp6 viable cells/ml.
    Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
    Preservation: Freeze medium: Complete growth medium, 95%; DMSO, 5%
    Storage temperature: liquid nitrogen vapor phase
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
    recommended serum:ATCC 30-2020
    tumor cell line established from the same patient:ATCC CRL-2338
    purified DNA:ATCC CRL-2339D
    purified RNA:ATCC CRL-2339R
    References: 38266: Gazdar AF, et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78: 766-774, 1998. PubMed: 9833771

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • The Nitroreductase/CB1954 Enzyme-Prodrug System

      The prodrug CB1954 (5-[aziridin-1-yl]-2,4-dinitrobenzamide) is a weak monofunctional alkylating agent originally synthesized at the Chester Beatty Laboratories in the late 1960s (1 ). The antitumor activity of CB1954 was determined

    • Direct DNA Injection (p53) into HCC Tumors

      Liver tumors, specially HCC, are among the most common malignancies in the world, and their annual world incidence is about 250,000 cases, with a male to female ratio 4:1 (1 ). HCC is one of the most important neoplasms in tropical

    • 应用技巧:BL-420F(S)USB驱动程序安装方法

      1、 首先安装 BL-420F 系统应用软件,安装完成后,驱动程序被复制到硬盘上,注意,你在光盘上是找不到驱动程序的。 安装应用软件后设备驱动程序在硬盘上的位置 2、 如果是原来已经安装驱动程序,但是驱动程序安装有问题,此时你需要更新驱动程序,更新的方法是:在「我的电脑」上单击右键弹出快捷菜单,选择属性,将弹出系统属性对话框,参见下图。 系统属性对话框 3、 在「系统属性」对话框中选择顶部的「硬件」栏,然后单击「设备管理器」按钮弹出「设备管理器」对话

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥900
    安元生物科技(南京)有限公司
    2025年07月16日询价
    ¥3200
    上海酶研生物科技有限公司
    2026年01月12日询价
    询价
    上海雅吉生物科技有限公司
    2025年06月28日询价
    询价
    上海彩佑实业有限公司
    2025年07月05日询价
    ¥3000
    博辉生物科技(广州)有限公司
    2025年12月26日询价
    HCC1954 BL
    询价